The Anti-Inflammatory Effect of Zhibaidihuang Decoction on Recurrent Oral Ulcer with Sirt1 as the Key Regulatory Target

<div>HPLC-QTOF/MS analysis of the serum from the ZBDHD-H treated rat. (a) HPLC-based analysis of serum. (b) PCA score plot of serum samples between the rats in ZBDHD and those in control group (R2X = 0.42, Q2 = 0.0913); (c) PLS-DA score plot between the two groups (R2X = 0.281, R2Y = 0.953, Q2 = 0.777); and (d) OPLS-DA score plot between the two groups (R2X = 0.281, R2Y = 0.953, Q2 = 0.772): control group and ZBDHD group.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: The Anti-Inflammatory Effect of Zhibaidihuang Decoction on Recurrent Oral Ulcer with Sirt1 as the Key Regulatory Target 